Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China flag China · Delayed Price · Currency is CNY
17.23
-0.09 (-0.52%)
Oct 28, 2026, 10:35 AM CST

SHA:605369 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,1861,1361,115975.081,4691,194
Revenue Growth
5.54%1.84%14.37%-33.61%22.98%43.95%
Gross Profit
326.81305.3363.12313.66574.54525.42
Operating Income
128.697.24154.18109.49324.22336.02
Net Income
71.551.51171.63109.13326.04310.99
Earnings Per Share
-0.230.780.491.481.41
EPS Growth
--70.51%58.25%-66.80%5.05%11.25%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Medical Testing
480.52
Blood Collection
279.6
Collection
138.55
Medical Care
90.53
Pharmaceutical Packaging
40.63
Commerce
43.32
Others
42.59
Total
1,116

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
694.75625.45443.66447.68753.23808.42
Total Debt
177.42164.3751.9835.480.310.94
Net Cash (Debt)
517.33461.08391.68412.19752.92807.49
Net Cash Growth
25.30%17.72%-4.98%-45.25%-6.76%-0.72%
Net Cash Per Share
-2.061.781.863.433.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
324.16253.96210.38185.39282.75372.99
Capital Expenditures
-132.62-111.6-109.61-121.82-172.18-275.56
Free Cash Flow
191.54142.35100.7763.57110.5797.43
Free Cash Flow Growth
84.36%41.26%58.53%-42.51%13.49%-27.08%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.54%26.88%32.56%32.17%39.12%44.00%
Operating Margin
10.84%8.56%13.83%11.23%22.07%28.14%
Pretax Margin
7.19%5.53%16.92%12.23%25.24%30.21%
Profit Margin
6.03%4.54%15.39%11.19%22.20%26.04%
FCF Margin
16.14%12.53%9.04%6.52%7.53%8.16%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1500.1500.5000.4080.1530.704
Dividend Per Share Growth
-75.58%-70.00%22.49%166.62%-78.26%7.33%
Dividend Yield
0.87%0.80%2.49%1.43%0.28%0.96%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
53.1879.7325.5857.6136.4851.89
Forward PE
20.2126.8917.3926.5525.2545.56
P/FCF Ratio
19.8528.8543.5698.89107.58165.62
PS Ratio
3.203.623.946.458.1013.51